| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |